News - gemcitabine Hcl


Current filters:

gemcitabine Hcl

Popular Filters

US FDA backs Abraxane for metastatic pancreatic cancer


US biotech firm Celgene (Nasdaq: CELG) said on Friday (September 6) that the US Food and Drug Administration…

AbraxaneBiotechnologyCelgenegemcitabine HclNorth AmericaOncologyRegulation

Celgene's Abraxane plus gemcitabine extends survival in pancreatic cancer patients


US biotech firm Celgene Corp (Nasdaq: CELG) says that its Phase III clinical trial of Abraxane (nab-paclitaxel)…

AbraxaneBiotechnologyCelgenegemcitabine HclOncologyResearch

Amgen halts ganitumab study on little hope of success


USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, late yesterday revealed…

AmgenBiotechnologyganitumabgemcitabine HclOncologyResearch

Hospira gains US approval of solution version of gemcitabine injection


US generic injectable drug leader Hospira (NYSE: HSP) says the US Food and Drug Administration has approved…

Eli Lillygemcitabine HclGemzarGenericsHospiraNorth AmericaOncologyRegulation

Back to top